Cargando…

Developing a medical device-grade T(2) phantom optimized for myocardial T(2) mapping by cardiovascular magnetic resonance

INTRODUCTION: A long T(2) relaxation time can reflect oedema, and myocardial inflammation when combined with increased plasma troponin levels. Cardiovascular magnetic resonance (CMR) T(2) mapping therefore has potential to provide a key diagnostic and prognostic biomarkers. However, T(2) varies by s...

Descripción completa

Detalles Bibliográficos
Autores principales: Topriceanu, Constantin-Cristian, Fornasiero, Massimiliano, Seo, Han, Webber, Matthew, Keenan, Kathryn E., Stupic, Karl F., Bruehl, Rüdiger, Ittermann, Bernd, Price, Kirsty, McGrath, Louise, Pang, Wenjie, Hughes, Alun D., Nezafat, Reza, Kellman, Peter, Pierce, Iain, Moon, James C., Captur, Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026458/
https://www.ncbi.nlm.nih.gov/pubmed/36935515
http://dx.doi.org/10.1186/s12968-023-00926-z
_version_ 1784909544862777344
author Topriceanu, Constantin-Cristian
Fornasiero, Massimiliano
Seo, Han
Webber, Matthew
Keenan, Kathryn E.
Stupic, Karl F.
Bruehl, Rüdiger
Ittermann, Bernd
Price, Kirsty
McGrath, Louise
Pang, Wenjie
Hughes, Alun D.
Nezafat, Reza
Kellman, Peter
Pierce, Iain
Moon, James C.
Captur, Gabriella
author_facet Topriceanu, Constantin-Cristian
Fornasiero, Massimiliano
Seo, Han
Webber, Matthew
Keenan, Kathryn E.
Stupic, Karl F.
Bruehl, Rüdiger
Ittermann, Bernd
Price, Kirsty
McGrath, Louise
Pang, Wenjie
Hughes, Alun D.
Nezafat, Reza
Kellman, Peter
Pierce, Iain
Moon, James C.
Captur, Gabriella
author_sort Topriceanu, Constantin-Cristian
collection PubMed
description INTRODUCTION: A long T(2) relaxation time can reflect oedema, and myocardial inflammation when combined with increased plasma troponin levels. Cardiovascular magnetic resonance (CMR) T(2) mapping therefore has potential to provide a key diagnostic and prognostic biomarkers. However, T(2) varies by scanner, software, and sequence, highlighting the need for standardization and for a quality assurance system for T(2) mapping in CMR. AIM: To fabricate and assess a phantom dedicated to the quality assurance of T(2) mapping in CMR. METHOD: A T(2) mapping phantom was manufactured to contain 9 T(1) and T(2) (T(1)|T(2)) tubes to mimic clinically relevant native and post-contrast T(2) in myocardium across the health to inflammation spectrum (i.e., 43–74 ms) and across both field strengths (1.5 and 3 T). We evaluated the phantom’s structural integrity, B(0) and B(1) uniformity using field maps, and temperature dependence. Baseline reference T(1)|T(2) were measured using inversion recovery gradient echo and single-echo spin echo (SE) sequences respectively, both with long repetition times (10 s). Long-term reproducibility of T(1)|T(2) was determined by repeated T(1)|T(2) mapping of the phantom at baseline and at 12 months. RESULTS: The phantom embodies 9 internal agarose-containing T(1)|T(2) tubes doped with nickel di-chloride (NiCl(2)) as the paramagnetic relaxation modifier to cover the clinically relevant spectrum of myocardial T(2). The tubes are surrounded by an agarose-gel matrix which is doped with NiCl(2) and packed with high-density polyethylene (HDPE) beads. All tubes at both field strengths, showed measurement errors up to ≤ 7.2 ms [< 14.7%] for estimated T(2) by balanced steady-state free precession T(2) mapping compared to reference SE T(2) with the exception of the post-contrast tube of ultra-low T(1) where the deviance was up to 16 ms [40.0%]. At 12 months, the phantom remained free of air bubbles, susceptibility, and off-resonance artifacts. The inclusion of HDPE beads effectively flattened the B(0) and B(1) magnetic fields in the imaged slice. Independent temperature dependency experiments over the 13–38 °C range confirmed the greater stability of shorter vs longer T(1)|T(2) tubes. Excellent long-term (12-month) reproducibility of measured T(1)|T(2) was demonstrated across both field strengths (all coefficients of variation < 1.38%). CONCLUSION: The T(2) mapping phantom demonstrates excellent structural integrity, B(0) and B(1) uniformity, and reproducibility of its internal tube T(1)|T(2) out to 1 year. This device may now be mass-produced to support the quality assurance of T(2) mapping in CMR. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12968-023-00926-z.
format Online
Article
Text
id pubmed-10026458
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100264582023-03-21 Developing a medical device-grade T(2) phantom optimized for myocardial T(2) mapping by cardiovascular magnetic resonance Topriceanu, Constantin-Cristian Fornasiero, Massimiliano Seo, Han Webber, Matthew Keenan, Kathryn E. Stupic, Karl F. Bruehl, Rüdiger Ittermann, Bernd Price, Kirsty McGrath, Louise Pang, Wenjie Hughes, Alun D. Nezafat, Reza Kellman, Peter Pierce, Iain Moon, James C. Captur, Gabriella J Cardiovasc Magn Reson Research INTRODUCTION: A long T(2) relaxation time can reflect oedema, and myocardial inflammation when combined with increased plasma troponin levels. Cardiovascular magnetic resonance (CMR) T(2) mapping therefore has potential to provide a key diagnostic and prognostic biomarkers. However, T(2) varies by scanner, software, and sequence, highlighting the need for standardization and for a quality assurance system for T(2) mapping in CMR. AIM: To fabricate and assess a phantom dedicated to the quality assurance of T(2) mapping in CMR. METHOD: A T(2) mapping phantom was manufactured to contain 9 T(1) and T(2) (T(1)|T(2)) tubes to mimic clinically relevant native and post-contrast T(2) in myocardium across the health to inflammation spectrum (i.e., 43–74 ms) and across both field strengths (1.5 and 3 T). We evaluated the phantom’s structural integrity, B(0) and B(1) uniformity using field maps, and temperature dependence. Baseline reference T(1)|T(2) were measured using inversion recovery gradient echo and single-echo spin echo (SE) sequences respectively, both with long repetition times (10 s). Long-term reproducibility of T(1)|T(2) was determined by repeated T(1)|T(2) mapping of the phantom at baseline and at 12 months. RESULTS: The phantom embodies 9 internal agarose-containing T(1)|T(2) tubes doped with nickel di-chloride (NiCl(2)) as the paramagnetic relaxation modifier to cover the clinically relevant spectrum of myocardial T(2). The tubes are surrounded by an agarose-gel matrix which is doped with NiCl(2) and packed with high-density polyethylene (HDPE) beads. All tubes at both field strengths, showed measurement errors up to ≤ 7.2 ms [< 14.7%] for estimated T(2) by balanced steady-state free precession T(2) mapping compared to reference SE T(2) with the exception of the post-contrast tube of ultra-low T(1) where the deviance was up to 16 ms [40.0%]. At 12 months, the phantom remained free of air bubbles, susceptibility, and off-resonance artifacts. The inclusion of HDPE beads effectively flattened the B(0) and B(1) magnetic fields in the imaged slice. Independent temperature dependency experiments over the 13–38 °C range confirmed the greater stability of shorter vs longer T(1)|T(2) tubes. Excellent long-term (12-month) reproducibility of measured T(1)|T(2) was demonstrated across both field strengths (all coefficients of variation < 1.38%). CONCLUSION: The T(2) mapping phantom demonstrates excellent structural integrity, B(0) and B(1) uniformity, and reproducibility of its internal tube T(1)|T(2) out to 1 year. This device may now be mass-produced to support the quality assurance of T(2) mapping in CMR. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12968-023-00926-z. BioMed Central 2023-03-20 /pmc/articles/PMC10026458/ /pubmed/36935515 http://dx.doi.org/10.1186/s12968-023-00926-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Topriceanu, Constantin-Cristian
Fornasiero, Massimiliano
Seo, Han
Webber, Matthew
Keenan, Kathryn E.
Stupic, Karl F.
Bruehl, Rüdiger
Ittermann, Bernd
Price, Kirsty
McGrath, Louise
Pang, Wenjie
Hughes, Alun D.
Nezafat, Reza
Kellman, Peter
Pierce, Iain
Moon, James C.
Captur, Gabriella
Developing a medical device-grade T(2) phantom optimized for myocardial T(2) mapping by cardiovascular magnetic resonance
title Developing a medical device-grade T(2) phantom optimized for myocardial T(2) mapping by cardiovascular magnetic resonance
title_full Developing a medical device-grade T(2) phantom optimized for myocardial T(2) mapping by cardiovascular magnetic resonance
title_fullStr Developing a medical device-grade T(2) phantom optimized for myocardial T(2) mapping by cardiovascular magnetic resonance
title_full_unstemmed Developing a medical device-grade T(2) phantom optimized for myocardial T(2) mapping by cardiovascular magnetic resonance
title_short Developing a medical device-grade T(2) phantom optimized for myocardial T(2) mapping by cardiovascular magnetic resonance
title_sort developing a medical device-grade t(2) phantom optimized for myocardial t(2) mapping by cardiovascular magnetic resonance
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026458/
https://www.ncbi.nlm.nih.gov/pubmed/36935515
http://dx.doi.org/10.1186/s12968-023-00926-z
work_keys_str_mv AT topriceanuconstantincristian developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance
AT fornasieromassimiliano developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance
AT seohan developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance
AT webbermatthew developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance
AT keenankathryne developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance
AT stupickarlf developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance
AT bruehlrudiger developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance
AT ittermannbernd developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance
AT pricekirsty developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance
AT mcgrathlouise developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance
AT pangwenjie developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance
AT hughesalund developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance
AT nezafatreza developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance
AT kellmanpeter developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance
AT pierceiain developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance
AT moonjamesc developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance
AT capturgabriella developingamedicaldevicegradet2phantomoptimizedformyocardialt2mappingbycardiovascularmagneticresonance